Hamid NA,Mitchell RD,Mocroft P.Targeting the subthalamic nucleus for deep brain stimulation:technical approach and fusion of pre-and postoperative MRimages to define accuracy of lead placement[J].Journal of Neurology Neurosurgery and Psychiatry,2005,76:409-414.
[2]
Jung YJ,Kim HJ,Jeon BSH.An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease[J].JAMA Neurology,2015,72:504-510.
[3]
Tomlinson CL,Stowe R,Patel S,et al.Systematic review of levodopa dose equivalency reporting in Parkinson's disease[J].Movement Disorders,2010,25:2 649-2 653.
[4]
Levy R,Hutchison WD,Lozano,AM.Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity[J].Journal of Neuroscience,2002,22:2 855-2 861.
[5]
Ivan ME,Yarlagadda J,Saxena AP.Brain shift during bur hole-based procedures using interventional MRI[J].Journal of Neurosurgery,2014,121:149-160.
[6]
张建国.脑深部电刺激术的现状与未来[J].中华神经外科杂志,2010,26(5):385-386.Zhang JG.Current status and the future of deep brain stimulation[J].Chinese Journal of Neurosurgery,2010,26(5):385-386.
[7]
Angeles Mena M,Jose Casarejos M,Maria Solano R.Half a century of L-DOPA[J].Current Topics in Medicinal Chemistry,2009,9:880-893.
[8]
Solla P,Cannas A,Marrosu F.Dopamine agonist withdrawal syndrome in Parkinson's disease[J].Journal of the Neurological Sciences,2017,382:47-48.
[9]
Asha MJ,Fisher B,Kausar J.Subthalamic deep brain stimulation under general anesthesia and neurophysiological guidance while on dopaminergic medication:comparative cohort study[J].Acta Neurochirurgica,2018,160:823-829.
[10]
中国帕金森病脑深部电刺激疗法专家组.中国帕金森病脑深部电刺激疗法专家共识[J].中华神经外科杂志,2012,28(8):855-857.Chinese Expert Group of Deep Brain Stimulation Therapy for Parkinson''s Disease.Chinese expert consensus on deep brain stimulation therapy for Parkinson's disease[J].Chinese Journal of Neurosurgery,2012,28(8):855-857.
[11]
Gelb DJ,Oliver E,Gilman S.Diagnostic criteria for Parkinson disease[J].Archives of Neurology,1999,56:33-39.
[12]
Brown P,Williams D.Basal ganglia local field potential activity:Character and functional significance in the human[J].Clinical Neurophysiology,2005,116:2 510-2 519.
[13]
Brown P,Oliviero A,Mazzone P.Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease[J].Journal of Neuroscience,2001,21:1 033-1 038.
[14]
Asha MJ,Kausar J,Krovvidi H.The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA:can we operate on patients‘on medications’[J]?Acta Neurochirurgica,2016,158:387-393.
[15]
Maltete D,Navarro S,Welter ML.Subthalamic stimulation in Parkinson disease-With or without anesthesia[J]?.Archives of Neurology,2004,61:390-392.
[16]
LeWitt PA.Levodopa Therapy for Parkinson's disease:pharmacokinetics and pharmacodynamics[J].Movement Disorders,2015,30:64-72.
[17]
Schlaier JR,Habermeyer C,Janzen A.The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson's disease[J].Acta Neurochirurgica,2013,155:357-366.
